Sophie Erhardt, Professor of Experimental Psychiatry and Head of the Department of Physiology and Pharmacology at Karolinska Institutet, has been awarded the 2026 Musajo Memorial Medal. The award recognises her research on how tryptophan metabolism affects brain health and psychiatric disorders.
The Musajo Memorial Medal is the highest honour awarded by the International Society for Tryptophan Research (ISTRY). Professor Sophie Erhardt received the medal at the society’s international conference in Padua, Italy, held on 10-12 June 2026. It was presented by Professor Robert Schwarcz, who received the award in 2015.

“It is a great honour and a fitting recognition of the research group’s collective work,” says Sophie Erhardt.
Sophie Erhardt’s research focuses on the interplay between the immune system and the brain. She has demonstrated the importance of immune-mediated activation of the kynurenine pathway, one of the body’s pathways for breaking down the amino acid tryptophan, in psychiatric disorders. Her research has contributed to a greater understanding of schizophrenia and cognitive impairment.
Her research group is now working to develop drug candidates designed to normalise kynurenic acid signalling, with the aim of developing new treatments for immune-induced cognitive impairment. Kynurenic acid is a metabolite produced during tryptophan breakdown.
Researchers are awarded the Musajo Memorial Medal that recognizes their outstanding lifetime professional contribution to tryptophan field or related areas by means of scientific research and beyond. The medal was established in 1995 and is named after Professor Luigi Musajo, who conducted pioneering work in the field in Padua.